NASDAQ: MEDPMedpace Holdings Inc Stock
$352.22+1.69 (+0.48%)
Updated Dec 9, 2024
MEDP Price
$352.22
Fair Value Price
$420.01
Market Cap
$10.95B
52 Week Low
$277.72
52 Week High
$459.77
P/E
29.77x
P/B
12.42x
P/S
5x
PEG
6.47x
Dividend Yield
N/A
Revenue
$2.07B
Earnings
$365.67M
Gross Margin
29.7%
Operating Margin
19.98%
Profit Margin
17.7%
Debt to Equity
1.36
Operating Cash Flow
$575M
Beta
1.23
Next Earnings
Feb 10, 2025
Ex-Dividend
N/A
Next Dividend
N/A
MEDP Overview
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, it offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The company was founded in 1992 and is based in Cincinnati, Ohio.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine MEDP's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
Zen Rating Component Grades
C
Value
C
Growth
D
Momentum
C
Sentiment
C
Safety
A
Financials
C
Artificial Intelligence
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Be the first to know about important MEDP news, forecast changes, insider trades & much more!
MEDP News
Overview
Due Diligence Score
–
Industry Average (24)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how MEDP scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
MEDP ($352.22) is undervalued by 16.14% relative to our estimate of its Fair Value price of $420.01 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
MEDP ($352.22) is not significantly undervalued (16.14%) relative to our estimate of its Fair Value price of $420.01 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
MEDP ($352.22) is trading above... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more MEDP due diligence checks available for Premium users.
Valuation
MEDP fair value
Fair Value of MEDP stock based on Discounted Cash Flow (DCF)
Price
$352.22
Fair Value
$420.01
Undervalued by
16.14%
MEDP ($352.22) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
MEDP ($352.22) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
MEDP ($352.22) is trading above... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
MEDP price to earnings (PE)
For valuing profitable companies with steady earnings
Company
29.77x
Industry
19.93x
Market
29.44x
MEDP is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
MEDP is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation
MEDP price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
12.42x
Industry
4.12x
MEDP is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
MEDP price to earnings growth (PEG)
For valuing profitable companies with growth potential
MEDP is poor value relative... subscribe to Premium to read more.
PEG Value Valuation
MEDP's financial health
Profit margin
Revenue
$533.3M
Net Income
$96.4M
Profit Margin
18.1%
MEDP's Earnings (EBIT) of $413.79M... subscribe to Premium to read more.
Interest Coverage Financials
MEDP's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$2.1B
Liabilities
$1.2B
Debt to equity
1.36
MEDP's short-term liabilities ($1.04B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
MEDP's short-term assets ($1.03B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
MEDP's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
MEDP's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$149.1M
Investing
-$10.5M
Financing
$6.3M
MEDP's operating cash flow ($574.54M)... subscribe to Premium to read more.
Debt Coverage Financials
MEDP vs Diagnostic & Research Stocks
Medpace Holdings Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.